We’ve run the current mobile device numbers and it’s time to take a look at whether pMD’s medical market share supports the greater quarterly expectations for Apple users worldwide.
iOS vs. Android:
The chart comparison between Q2 and Q3 reveals that Apple has, in fact, lost a notable slice of pMD's market share to Android. Although Apple is inarguably the dominant device of choice among doctors, nurse practitioners, and physician assistants using pMD for charge capture and secure messaging, we've begun to see an ever-so-slight upward tick among Android users throughout our weekly device wars.
iPhone By Model:
The internal iPhone breakdown over the last quarter shows a significant favorable shift toward newer models. The iPhone 6 and 6 Plus now account for the majority of pMD's iPhone users, while the older iPhone 4, 4S, and 5 models have trimmed down to make up less than 25 percent of the device pie. These impressive upgrade numbers support the stronger than expected iPhone sales over the last three months, and we should see Apple post bullish Q3 earnings in tomorrow’s announcement. Of course, we can't rule out any surprises or wacky turn of events.... Apple is, after all, getting sued for using the term "iWatch" in its ads when referring to their very own Apple Watch (another company allegedly already owns that trademark.) Still, we'll be glued to our iPhones, Macs, and Apple Watches tomorrow at 2pm PT for the fiscal results.